<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(3)</volume><submitter>Han YJ</submitter><pubmed_abstract>&lt;b>Rationale:&lt;/b> Coronavirus disease 2019 (COVID-19) has spread worldwide and poses a threat to humanity. However, no specific therapy has been established for this disease yet. We conducted a systematic review to highlight therapeutic agents that might be effective in treating COVID-19. &lt;b>Methods:&lt;/b> We searched Medline, Medrxiv.org, and reference lists of relevant publications to identify articles of &lt;i>in vitro&lt;/i>, &lt;i>in vivo&lt;/i>, and clinical studies on treatments for severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and COVID-19 published in English until the last update on October 11, 2020. &lt;b>Results:&lt;/b> We included 36 studies on SARS, 30 studies on MERS, and 10 meta-analyses on SARS and MERS in this study. Through 12,200 title and 830 full-text</pubmed_abstract><journal>Theranostics</journal><pagination>1207-1231</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7738873</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of &lt;i>in vitro&lt;/i>, &lt;i>in vivo&lt;/i>, and clinical trials.</pubmed_title><pmcid>PMC7738873</pmcid><pubmed_authors>Ghayda RA</pubmed_authors><pubmed_authors>Oh H</pubmed_authors><pubmed_authors>Effenberger M</pubmed_authors><pubmed_authors>Lee J</pubmed_authors><pubmed_authors>Kresse D</pubmed_authors><pubmed_authors>Kronbichler A</pubmed_authors><pubmed_authors>Denicolo S</pubmed_authors><pubmed_authors>Shin H</pubmed_authors><pubmed_authors>Jacob L</pubmed_authors><pubmed_authors>Shin JI</pubmed_authors><pubmed_authors>Seong D</pubmed_authors><pubmed_authors>Koyanagi A</pubmed_authors><pubmed_authors>Radua J</pubmed_authors><pubmed_authors>Ryu S</pubmed_authors><pubmed_authors>Yang JW</pubmed_authors><pubmed_authors>Kang W</pubmed_authors><pubmed_authors>Yoon S</pubmed_authors><pubmed_authors>Nam SW</pubmed_authors><pubmed_authors>Smith L</pubmed_authors><pubmed_authors>Lee JY</pubmed_authors><pubmed_authors>Kim JS</pubmed_authors><pubmed_authors>Han YJ</pubmed_authors><pubmed_authors>Dragioti E</pubmed_authors><pubmed_authors>Hong SH</pubmed_authors><pubmed_authors>Lee KH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of &lt;i>in vitro&lt;/i>, &lt;i>in vivo&lt;/i>, and clinical trials.</name><description>&lt;b>Rationale:&lt;/b> Coronavirus disease 2019 (COVID-19) has spread worldwide and poses a threat to humanity. However, no specific therapy has been established for this disease yet. We conducted a systematic review to highlight therapeutic agents that might be effective in treating COVID-19. &lt;b>Methods:&lt;/b> We searched Medline, Medrxiv.org, and reference lists of relevant publications to identify articles of &lt;i>in vitro&lt;/i>, &lt;i>in vivo&lt;/i>, and clinical studies on treatments for severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and COVID-19 published in English until the last update on October 11, 2020. &lt;b>Results:&lt;/b> We included 36 studies on SARS, 30 studies on MERS, and 10 meta-analyses on SARS and MERS in this study. Through 12,200 title and 830 full-text</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-03-15T21:41:28.081Z</modification><creation>2021-02-21T03:05:28Z</creation></dates><accession>S-EPMC7738873</accession><cross_references><pubmed>33391531</pubmed><doi>10.7150/thno.48342</doi></cross_references></HashMap>